发明名称 Process for the preparation of enantiomerically pure <i>tert</i>-leucine
摘要 Enantiomerically pure L-tert-leucine and D-tert-leucine were prepared from (DL)-tert-leucine by diastereomeric salt formation using dibenzoyl-d-tartaric acid as the resolving agent.
申请公布号 US8835676(B2) 申请公布日期 2014.09.16
申请号 US201113154612 申请日期 2011.06.07
申请人 Divi's Laboratories Ltd. 发明人 Divi Murali Krishna Prasad;Padakandla Gundu Rao;Rao Mysore Aswatha Narayana;Nowshuddin Shaik
分类号 C07B57/00;C07C227/34;C07C67/52;C07C67/28 主分类号 C07B57/00
代理机构 Caesar, Rivise, Bernstein, Cohen &amp; Pokotilow, Ltd. 代理人 Caesar, Rivise, Bernstein, Cohen &amp; Pokotilow, Ltd.
主权项 1. A process for the preparation of enantiomerically pure tertiary-leucine which is L-tert-leucine by resolution of (DL)-tertiary-leucine by forming a diastereomeric salt using a resolving agent selected from optically active tartaric acid derivatives, comprising: (a) dissolving (DL)-tent-leucine in a polar solvent and treating it with dibenzoyl-d-tartaric acid to create a suspension, (b) filtering the suspension to obtain selectively L-tert-leucine dibenzoyl-d-tartrate salt, (c) treating the tartrate salt with an acid to obtain an acid salt of L-tert-leucine and free dibenzoyl-d-tartaric acid, and (d) neutralizing the acid salt to obtain free L-tert-leucine.
地址 IN